Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print

Latest Articles in pharma

The Future Of Healthcare In India

Estimates indicate that healthcare costs drive an additional 4% of Indian families, over 50 million people, into poverty each year

Read More

Importance Of Effective Health Information Systems For NCDs

NCDs are primarily driven by four major chronic conditions - cardiovascular disease, diabetes, chronic respiratory disease and cancers - which together are responsible for over 80 per cent of the NCD related mortality

Read More

The Social Circuit: The Mobile Movement

Twitter users will now be able to say more in the 140 character limit as Twitter is doing away with certain rules

Read More

India Now Most Open Economy In World For FDI, Says PM Narendra Modi

The Modi-led government relaxed Foreign Direct Investment norms in a host of sectors including civil aviation, single-brand retail, defence and pharma by permitting more investments under automatic route

Read More

Govt Relaxes FDI Norms In Civil Aviation, Defence, Pharma

Other sectors in which FDI norms have been relaxed include e-commerce in food products, broadcasting carriage services, private security agencies and animal husbandry

Read More

IPA Seeks To Eliminate Misconceptions Around ePharmacy Model

The Internet Pharmacy Association brings together the legitimate players in this segment to improve the last mile access of medicines using digital technologies without compromising the safety of the patient

Read More

Aurobindo Pharma Fourth Quarter Profit Jumps 40%; Shares Rise 4%

The company's shares rose as much as 4 per cent to Rs 786.80 in early trade on Tuesday, while the broader market was down 0.15 per cent

Read More

Dr Reddy's Acquires 6 OTC Brands From Ducere Of US

Dr Reddy's Laboratories said on Wednesday that it has acquired a range of consumer health or over-the-counter brands from the US-based Ducere Pharma Llc for an undisclosed sum

Read More

Ajanta Pharma Gets USFDA Approval Of Zolmitriptan Tablets

USFDA has granted Ajanta Pharma 9 ANDA final approvals and two tentative approvals. Additional 15 ANDAs are under review with the American regulator

Read More

Lupin Fourth Quarter Profit Up 48%, Beats Estimates

Lupin has benefitted in recent months from a steady pace of new drug approvals in the United States at a time when most of its peers have been facing delays in getting approvals due to regulatory troubles

Read More

Pfizer Approaches Medivation About Potential Takeover

Pfizer's approach comes less than a week after Sanofi went public with its $52.50 per share cash offer, complaining that Medivation refused to engage.

Read More

Obama's Inversion Curbs Kill Pfizer's $160 Billion Allergan Deal

Pfizer will have to pay Allergan up to $400 million for its expenses as a result of terminating the deal, according to their merger agreement

Read More

Ajanta Pharma: A Dose Of Strong Medicine

Lacking the financial or operational muscle to compete with pharma giants, Ajanta focused on first-of-its-kind drugs to script a turnaround

Read More

Sensex Ends Lower For Second Day As Pharma Stocks Bleed

In volatile trading, equities fell for a second straight day on Tuesday as heavy losses in healthcare stocks countered advances in auto and banking sectors amid caution ahead of derivatives expiry and investors waiting for a speech by the US Federal Reserve Chair Janet Yellen

Read More

Drugs Ban | Partial Relief From High Court For Wockhardt, Glaxo And Griffon

The drugs which were subject matter of today's plea are Aceproxyvon, Viscodyne and Viscodyne-D of Wockhardt, Crocin Cold and Flu Max of Glaxo and Grilinctus syrup of Griffon.

Read More